Edges in Network
| Network | GSE25055_egf1520 - GSE25055 - SiGN-BN HC+Bootstrap |
| Network Description | Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | SPRY2 |
| Upstream (Parents) |
|---|
| (<<) ACTG1 → SPRY2 |
| (<<) ANKRD27 → SPRY2 |
| (<<) BCL2L13 → SPRY2 |
| (<<) CAV1 → SPRY2 |
| (<<) CAV3 → SPRY2 |
| (<<) CCDC88A → SPRY2 |
| (<<) CHST12 → SPRY2 |
| (<<) CISH → SPRY2 |
| (<<) CTGF → SPRY2 |
| (<<) CXCL2 → SPRY2 |
| (<<) DRD4 → SPRY2 |
| (<<) EFNB2 → SPRY2 |
| (<<) EGFR → SPRY2 |
| (<<) EMILIN2 → SPRY2 |
| (<<) FZD5 → SPRY2 |
| (<<) FZD7 → SPRY2 |
| (<<) GYPC → SPRY2 |
| (<<) ITGA6 → SPRY2 |
| (<<) JUNB → SPRY2 |
| (<<) KCTD12 → SPRY2 |
| (<<) KHDRBS3 → SPRY2 |
| (<<) KLF11 → SPRY2 |
| (<<) KRT14 → SPRY2 |
| (<<) MAFF → SPRY2 |
| (<<) MAP3K6 → SPRY2 |
| (<<) MEF2A → SPRY2 |
| (<<) NFIB → SPRY2 |
| (<<) NFIL3 → SPRY2 |
| (<<) PELO → SPRY2 |
| (<<) PIK3R5 → SPRY2 |
| (<<) PRNP → SPRY2 |
| (<<) RAP1A → SPRY2 |
| (<<) RHOQ → SPRY2 |
| (<<) RHOT2 → SPRY2 |
| (<<) ROCK2 → SPRY2 |
| (<<) RXRG → SPRY2 |
| (<<) SALL2 → SPRY2 |
| (<<) SOCS5 → SPRY2 |
| (<<) SYNPO → SPRY2 |
| (<<) TARS → SPRY2 |
| (<<) TK2 → SPRY2 |
| (<<) UBE2E3 → SPRY2 |
| (<<) WWTR1 → SPRY2 |
| Downstream (Children) |
|---|
| SPRY2 → CYP1A2 (>>) |
| SPRY2 → DUSP6 (>>) |
| SPRY2 → ENO2 (>>) |
| SPRY2 → GNAL (>>) |
| SPRY2 → GULP1 (>>) |
| SPRY2 → HSD17B2 (>>) |
| SPRY2 → MT3 (>>) |
| SPRY2 → RARB (>>) |
| SPRY2 → TGFB2 (>>) |
| SPRY2 → TNFRSF11A (>>) |
